Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11925617
SERIAL NO

17186724

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NORTHROP GRUMMAN SYSTEMS CORPORATION; CORPORATION AND EPICENTRX, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bednarski, Mark D Los Altos, US 24 593
Cannizzo, Louis Ogden, US 12 203
Knox, Susan Stanford, US 15 213
Ning, Shoucheng Palo Alto, US 14 196
Velarde, Stephen North Ogden, US 9 174
Wardle, Robert Logan, US 11 200
Warner, Kirstin Ogden, US 11 177

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 12, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 12, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 12, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00